BNKL — Bionik Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Bionik Laboratories, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.447	2.27	0.608	1.99	0.427
Net Total Accounts Receivable
Net Total Receivables	1.54	0.911	0.452	0.275	0.453
Total Inventory
Prepaid Expenses
Total Current Assets	3.75	5.83	3.43	4.58	2.78
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.193	0.154	0.094	0.091	0.442
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	30.7	18.5	8.79	4.68	3.36
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.27	5.2	4.1	1.49	2.31
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.27	5.2	5.51	1.75	5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	27.4	13.3	3.28	2.93	-1.64
Total Liabilities & Shareholders' Equity	30.7	18.5	8.79	4.68	3.36
Total Common Shares Outstanding